Quick Answer
NEPHROS INC reported Stockholders Equity of $10.20 million for fiscal year 2025.
NEPHROS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $10.20M | +18.8% |
| 2024 | $8.59M | +2.7% |
| 2023 | $8.36M | +49.5% |
| 2022 | $5.59M | -52.2% |
| 2021 | $11.70M | -6.6% |
| 2020 | $12.52M | +167.9% |
| 2019 | $4.67M | +23.1% |
| 2018 | $3.80M | +94.8% |
| 2017 | $1.95M | +192.4% |
| 2016 | $667.0K | +125.0% |
| 2015 | -$2.66M | +53.1% |
| 2014 | -$5.68M | -52.8% |
| 2013 | -$3.72M | -525.0% |
| 2012 | -$595.0K | -141.9% |
| 2011 | $1.42M | +952.6% |
| 2010 | $135.0K | -93.1% |
| 2009 | $1.96M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.01M | +22.4% | +4.2% |
| June 30, 2025 | $9.60M | +21.1% | +3.3% |
| March 31, 2025 | $9.29M | +13.6% | +8.2% |
| December 31, 2024 | $8.59M | +2.7% | +5.0% |
| September 30, 2024 | $8.17M | -5.2% | +3.1% |
| June 30, 2024 | $7.93M | -8.4% | -3.1% |
| March 31, 2024 | $8.18M | -8.0% | -2.1% |
| December 31, 2023 | $8.36M | +49.5% | -3.1% |
- NEPHROS INC showed an increase of +18.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, NEPHROS INC’s stockholders equity has grown by 421.0% (from $1.96 million to $10.20 million).
- The most recent figure is from NEPHROS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: